Tech Company Financing Transactions
IntegraGen Funding Round
On 7/16/2012, IntegraGen landed $2.5 million in funding from A Plus Finance.
Transaction Overview
Company Name
Announced On
7/16/2012
Transaction Type
Venture Equity
Amount
$2,450,000
Round
Undisclosed
Investors
Proceeds Purpose
Building upon an existing strong cash position, these funds will sustain the development of genetic tests in colorectal and liver cancer as well as speed up R&D and commercialization efforts in the field of autism molecular diagnostics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5 Rue de Henri Desbruères
Evry, 91000
France
Evry, 91000
France
Phone
Website
Email Address
Not Recorded
Overview
IntegraGen is a leader in genome analysis and the development and commercialization of molecular diagnostic tests for autism and oncology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bernard Courtieu
Chief Financial Officer
Laurence Lamotte
General Manager
Larry Yost
VP - Regulatory Affairs
Catherine David
VP - Sales
Emmanuel Martin
Browse more venture capital transactions:
Prev: 7/16/2012: Ivy venture capital transaction
Next: 7/16/2012: Diagnostic Photonics venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs